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Abstract
Background: This article was to present the sampling and measurements methods and the main preliminary findings
of the KERCADR cohort study (first round) in an urban and peri-urban setting, Kerman, southeastern Iran2009-11.
Method: 5900 (3238 female) people aged between 15 to 75 years were recruited in the household survey by non-
proportional to size one-stage cluster sampling. Trained internal specialists, general practitioners, clinical psychologists
and dentists have assessed the study subjects by person-assisted questionnaires regarding different NCD risk factors
including cigarette and opium smoking, physical activity, nutrition habits, anxiety, depression, obesity, hypertension
and oral health. Blood samples were also collected for determining FBS, HbA1c, cholesterol and triglyceride.
Weighted standardized prevalence estimates were calculated by STATA 10 survey analysis package.
Results: The participation rate was more than 95% in all subgroups. Cigarette smoking (18.4% vs. 1.2%), opium use
(17.8% vs. 3.0%) and triglyceridemia (16.1% vs. 12.0%) were significantly higher among men than women. In contrast,
women were presented with higher level of sever anxiety (29.1% vs. 16.7%), obesity (16.8% vs. 9.2%), low-physical
activity (45.1% vs. 39.2%) and uncontrolled diabetes (60.2% vs. 31.0%). More than 68% of all subjects have presented
with moderate to severe gingival index scores.
Conclusion: The first round of the KERCADR cohort with sufficient sample size and response rate provided precise
estimates for the main clinical and para-clinical NCD risk factors. These evidences need to be translated into public
health interventions and monitored in the next rounds of the cohort.
Keywords: Household survey, CAD risk factors, Cohort, Iran
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How did the study come about?
Kerman is the capital city of Kerman Province
located in south east of Iran about 1000km far
from the capital city, Tehran (Fig. 1). It’s popu-
lated by 540,000 inhabitants (estimated for 2010)
(1). People are mostly busy with white-collar
works at governmental sections, agriculture and
marketing.
The lifestyle patterns are typically aggregated in
families. In 2005, as part of the national survey on
non-communicable disease risk-factors
(NCDRFs) in Kerman province, 1614 inhabitants
aged 15 to 64 years were recruited. The familial
aggregation of NCDRFs such as physical inactiv-
ity, obesity, high blood pressure, hyper
cholestrolemia and high blood glucose with a risk
ratio of 1.5 to 3.5 have been reported in a study
published in 2007(2).
Fig.1: Kerman province and city
According to the national NCDRFs 2005-6 re-
port(3), the prevalence of different risk factors
among people living in Kerman were as follow:
overweight 42%,  obesity 12%, systolic and dias-
tolic blood pressure more than 140/90 mmHg,
12.1%, every day cigarette smoking reported at the
level of 18.6% in men.
When we look at the risk factors as one combined
factor, about 41.9% (CI95%, 33.7-50.5%) of the
inhabitants in Kerman have a raised risk factor
which put it at the 12th rank among the provinces
(out of the 31) in Iran(3). This high risk profile of
the Kerman community is translated into 37 inci-
dence case (per day) of myocardial infarction in
Kerman. All of these highlight the  susceptibility
of Kerman population for cardiac events(4).
When we look at the impact indicators, i.e. the
standardized crude mortality rate of all cardiac
diseases, Kerman with 320 deaths (per 100,000)
gets the 14th rank among the all provinces. In ad-
dition to cardiac risk-factors and diseases, the
province’s rank moved up to the 3rd position in
the country, considering the  standardized crude
mortality rate of addiction and drug-abuse related
disorders(5). Several studies has explored that
mental health and disorders including addiction,
depression affected a considerable proportion of
inhabitants in Kerman which is a public health
need among the all health priorities for this part of
the country(5).
As mentioned above, the national NCD risk
factor surveillance has been conducted in Iran
since 2005. It has been designed to provide
national estimates on major NCD risk factors by
repeated survey among the Iranian populations
aged from 25 to 65 years old. In line with the
national NCD risk factor strategic plan,
KERCADR has been designed and implemented
to monitor the CAD risk factors at individual level
(repeated measured among individuals rather than
community) with a prospective cohort study6. In
addition to basic routine NCD risk factors that are
captured in the national NCD surveillance,
KERCADR includes mental health (opium
dependency, depression, and anxiety), oral health
and HbA1c.
The present article aims to present the details of
the sampling, measurement and analysis
techniques applied in KERCADR to provide the
most valid and reliable estimates on NCD risk
factors and monitored the trend at the individual
levels in an urban setting in south-east of Iran. We
also present the preliminary results of the main
CAD risk measured in the first round of
KERCADR study and compared men and women
accordingly.
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What does the KERCADR cover?
The primary objectives of the study are:
1. To identify behavioral and biological risk
factors for non-communicable diseases by
a comprehensive assessment of self and
familial past medical history, demograph-
ics, occupational and educational status.
2. To identify behavioral and biological risk
factors for mental health disorders by a
comprehensive assessment of self and fa-
milial past medical history, demographics
and occupational and educational status.
3. To establish bio-bank for serum to be
used for further cross-sectional and nested
case-control studies
Who is in the sample?
The first round of the study has been initiated in
Kerman in 2009 to recruit 5900 subjects aged be-
tween 15 to 75 years old.
The details of the recruited sample and the key
findings are illustrated in Table 1. To maximize
the sample size to be efficient for all the NCD and
their risk factors, we have calculated the sample
size for a prevalence of 50%, and consider the
precision as the level of 5%. The initial calculation
for the sample size was 384.16 cases. We did not
apply the Finite Population Correction. However,
we have corrected the sample size based on eight
strata (15-24, 25-34, 35-54, 55-74 by sex), the de-
sign effect of 1.5 and the response rate 78% where
lead to 5900 as the final sample size (Fig. 2).
The project has been funded by Kerman Univer-
sity of Medical sciences with the grant number
88/110.
The sampling method was a one stage cluster
sampling. In the first stage, 250 postal codes
(called seeds) were selected randomly among an
updated roster of residential addresses in provin-
cial post office. The data collection team firstly
mapped the seeds and then contact them one by
one. After briefing the household’s member, all
the eligible members (15-75 years old) have been
listed in the Kish household coversheet and re-
cruited to the study.
Fig. 2: the sample size calculation formula
The written informed consent was signed by all of
the participants after ensuring their well-
understanding of the harm and benefits of the
participation in the survey. It should be noted that
the study protocol and procedures were reviewed
and approved by the Research Review Board of
the Kerman University of Medical Sciences (Ethic
code 88-110KA).
In the case of any household being absent for
twice, the other neighborhood households from
the right direction of the seed were approached
systematically and with the same method, eligible
people were asked to participate in the study. The
recruitment was continued to reach 24 subjects in
each cluster. All recruited people were given an
appointment card having the date, time and the
place of attending collaborating clinic for blood
sampling and face-to-face interview. They were
asked to be fasted for 12-14 hours before the ap-
pointment time in the morning and bring their
medicines with themselves.
In Fig. 3, the age distribution of the recruited sam-
ple is compared with the target population in Ker-
man (National consensus of population size for
2006). Base on the sampling methods (non-
proportionate to size), the younger age groups
were under-sampled and the older groups have
been over-sampled. Although this will bring more
precision to age-stratum specific estimates, the
total combined estimates have to be always stand-
ardized based on the real age distribution of the
target population.
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Fig. 3: The age distribution in the sample and target
population, (N=5900) Kerman, Iran, 2009-11
The standardized estimates (based on age and sex
subgroups) for the key measures of clinical and
para-clinical findings were presented separately for
men and women in Table 1.  The standardized
estimates are lower than the crude estimates. For
sake of simplicity, we did not present crude esti-
mates (as they have been confounded estimates).
The reason for this confounding is the over-sam-
pling of the older age-groups in the survey and the
direct standardization has removed this sort of
confounding.
For further analysis, we have considered house-
hold as the primary sampling unit (cluster). Pro-
portions of categorical and ordinal variables re-
ported by sex group and then compared using Chi
square test. The means and 95% confidence inter-
val (CI) of numerical variables were reported by
sex group and compared using Post-Survey Esti-
mation Student T-test. Association between dis-
orders and risk factors were calculated using Pois-
son regression model. All statistical analyses were
conducted under survey data analysis by STATA
v.11. P-Value less than 0.05 considered as signifi-
cant level.
How often they will be followed?
It is going to be repeated comparable surveys eve-
ry four to five years having the components of the
behavioral and biological measurements.
What has been measured?
 Behavioral risk factors: the nutritional ha-
bits were recorded as well as the food fre-
quency questionnaire for all study subjects.
Current and past smoking status also rec-
orded. Physical activity at home and work
places, daily movements and level of phys-
ical activities at recreation session was
measured by Global Physical Activity
Questionnaire (GPAQ) and Metabolic
Equivalents was used to express the inten-
sity of physical activities(6).
 Smoking and addiction status: Smoking
status was measured in different ways.
People were categorized as the current
smoker if they mentioned that they have
been smoking cigarette at the time of first
assessment round of the survey. For ad-
diction, a general practitioner asked the
participants to disclose whether they have
ever used any type of drug and still con-
tinue. Those with the positive drug history,
the type of drug was also asked and rec-
orded.
 Physical examination and biological risk
factors: anthropometric measurements as
height (a tape stadiometer with a mini-
mum measurement of 0.1 cm in a standing
position, without shoes, while the shoul-
ders were in a normal resting state) and
weight (light clothing without shoes meas-
ures by Seca 707 weighing Balance with
the range of 0.1 to 150 kg, with an accu-
racy of up to 100 gr), Waist circumference
(measured at the umbilical level and hip
circumference was measured at the max-
imal level over light clothing, using a non-
stretchable measuring tape, without any
pressure to the body surface; both were
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recorded to the nearest 0.1 cm), blood
pressure (standard mercury manometer–
Model RISHTER, Germany) and pulse
rate, fasting blood glucose (KIMIA Kit,
Code 890410, Iran) (HbA1C - NYCO-
CARD Kit, Code 1042184, Austria) - for
known diabetic cases and those with high
fasting blood glucose after two subsequent
measurements), Triglyceride (KIMIA Kit,
Code 890201, Iran), Total cholesterol (KI-
MIA Kit, Code 890303, Iran) (HDL –
PARS Kit, Code 89022, Iran) - and LDL
was calculated based on Frieldwald  for-
mula  [LDL = Total chol. – (HDL +
TG/5)].
Table 1: Standardized estimates for the clinical and para-clinical findings in KERCADR study round one,
(N=5900), Kerman, Iran, 2009-11
Male Female P-value(N=2662) (N=3238)
Frequency Percentage CI 95% Frequency Percentage CI 95%
Clinical Findings
Current daily cigarette smokers 602 18.40% 17.5-19.3% 55 1.20% 1.0-1.4% <0.0001
Current opium use (occasio-
nally or dependency) 674 17.80% 17.0-18.7% 176 3.00% 2.7-3.3% <0.0001
Severe Anxiety (BAI score>25) 439 16.70% 15.6-17.8% 1041 29.10% 28-30.2% <0.0001
Severe Depression (BDI
Score>46) 6 0.20% 0.1-0.3% 16 0.60% 0.4-0.8% <0.0001
Hypertension(BP≥140/90
mmHg or taking drugs) 558 10.70% 10.1-11.3% 775 10.70% 10.4-11.1% 0.9
Obese (BMI>=30) 269 9.20% 8.5-10.0% 779 16.80% 16.1-17.6% <0.0001
Low physical activity (<600
MET per week) 1091 39.20% 37.9-40.6% 1518 45.10% 43.8-46.4% <0.0001
Grade of Gingival index
Moderate (1<GI Score≤2) 1551 69.70% 68.4-71.0% 1902 65.40% 64.1-66.6% 0.05
Severe (GI Score>2) 62 2.90% 2.4-3.5% 81 2.70% 2.4-3.1%
DMFT(mean) 12.2 11.9-12.5 12.8 12.5-13.0 0.003
Para-Clinical Findings
Diabetes (FBS≥126 mg/dL or
taking drug or Insulin) 355 6.90% 6.4-7.4% 496 8.50% 8.1-9% 0.02
Uncontrolled Diabetes (HbA1c
≥7%) 174 31. 0% 25.3-37.3% 288 60.2% 52.0-68.4% 0.0001
Cholestrolemia (>200 mg/dL) 951 27.80% 26.8-28.9% 1401 30.10% 29.2-31.0% 0.1
Triglyceridemia (>200 mg/dL) 520 16.10% 15.2-17.1% 599 12.00% 11.4-12.6% 0.0002
* Estimates adjusted for Missing Response and also standardized based on the Kerman population size in 2006; MET: Metabolic
Equivalents, BMI: Body Mass Index, BP: Blood Pressure, FBS: Fasting Blood Sugar
 Medical history: Hypertension and Di-
abetes history as well as other cardiovascu-
lar and vascular diseases, the name of
medicines also were recorded by a general
practitioner. Accordingly, all types of med-
ical interventions and any of the men-
tioned disease in the immediate family
were also recorded. Blood pressure (BP)
was measured in sitting position after at
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least 10 minutes at rest. If abnormal, BP
was measured once again at the end of the
session (at least 30 minutes after the first
measurement) in the same conditions.
 Mental health: depression was measured
by a valid-translation of the 21-question
BECK-BDI questionnaire. Anxiety score
was measured by a valid-translation of the
21-question BECK Anxiety questionnaire,
both conducted by a face to face interview.
 Oral Health: Gingival Index, Dentition
Status and Community Periodontal Index
of Treatment Needs questionnaires were
used for measuring the Gingival and
DMFT indices and treatment needs re-
spectively. These were completed by a
dentist by inspection.
 Demographic measurements: age, sex, ed-
ucation, familial status, location and period
of residency in Kerman.
What are the main strengths of the
study?
The participation rate in all the suburban divisions
was more than 95%. All the non-response house-
holds have been tracked twice and if the house-
hold did not find at the end, one neighborhood
household was replaced. All the non-response in a
family was track-able by Kish form. This ap-
proach makes it possible to count the number of
non-response cases at the family which will be
used for weighted analysis based on the none-res-
ponses.
All the biomedical assessment were performed
free of charge for participants and the results with
a recommendation note based on the results re-
turned back to the study participants by local mail
delivery system and further consultancy and re-
quired services also provided accordingly. This
approach has improved the participation rate and
the acceptability of the study among the local
communities and families. And we believe this will
continue for the next rounds of the cohort.
For each participant, two subsamples of the serum
have been frozen and stored at -80oC for further
investigation as complementary case-cohort and
nested case-control studies.
Data entered into an Epi-data 3.1 database in
maximum three days of the interview.  Since it has
been done with a specific control with several
cross-check points, any type of inconsistency has
been reported to the data collection team for fur-
ther investigation and to be corrected even by re-
calling the study subjects.
Laboratory QC and QA
Laboratory exams for FBS, Chol, TG and HDL
have been done by Selectra E machine. The ma-
chine automatically has repeated the test based on
the following cut points (Table 2):
Table 2: The cutoffs for automated exam repeti-
tions
Lab. Exams Cutoffs for automated exam
repetition
FBS >400
Chol >500
TG >750
HDL <2  OR >440
Westgard rules have been used for the quality con-
trol. Shewhart chart has been developed for all the
laboratory examinations and according to the
standard deviation from the mean (SD), necessary
decisions have made. If the three rules have been
rejected, the test should be repeated. In the next
step, the laboratory technician will review the re-
sults and according to the following cutoffs (Table
3), the tests will be repeated.
In all cases, the results will be reported if in two
serial exams, the results will be in the range of ±5.
For, HbA1c, NYCOCARD kit is being used.
HbA1c results is comparing with the FBS as for
FBS equal to 126, we expected to have HbA1c
around 6.5 and for every unit increase in HbA1c,
FBS should be increase about 30. For example,
for a person with HbA1c of 8%, FBS expected to
be around 170. If the expected result varies more
than ±0.5 from the observed result, HbA1c will
be repeated.  The results will be reported if in two
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serial exams, the results will be in the range of
±0.5.
Table 3: The cutoffs for automated exam repetitions
Lab. Exams Cutoffs for automated exam repeti-
tion
FBS >115
Chol >250
TG >200
HDL Male : <30   Female :  <35
To control the quality of Selectra E machine, in a
daily basis, the machine will be calibrated based on
the standard controls from Roche Germany (Pro-
cured from KIMIA Pajoohan). The LOT number
for the standard controls are varies (as the dura-
tion of the study is about 2 years) but has been
registered.
For the external quality control, four specimens
from the central Academic Laboratory in Kerman
and two specimens from national reference labor-
atory have been sent to the laboratory to be tested
and return back the results.  If the results were not
in the acceptable range, they will receive the feed-
backs. Regarding the above tests, the quality has
been approved up to now.
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